Longest acting erythro poietin analogue is
**Core Concept**
Erythropoietin analogues are recombinant human erythropoietin (rHuEPO) derivatives used to stimulate erythropoiesis in patients with anemia of chronic disease or those undergoing dialysis. These analogues have different pharmacokinetic profiles, which determine their duration of action.
**Why the Correct Answer is Right**
The longest acting erythropoietin analogue is **methoxy polyethylene glycol-epoetin beta (Mircera)**. It has a half-life of approximately 134 hours, which allows for less frequent dosing compared to other erythropoietin analogues. Mircera achieves this by covalently binding polyethylene glycol (PEG), which reduces renal clearance and prolongs its biological activity.
**Why Each Wrong Option is Incorrect**
**Option A:** Darbepoetin alfa has a longer half-life than epoetin alfa but is not the longest acting analogue. Its half-life is approximately 48 hours.
**Option B:** Epoetin alfa has a half-life of about 8-10 hours and requires more frequent dosing.
**Option C:** Epoetin beta has a similar pharmacokinetic profile to epoetin alfa and is not the longest acting analogue.
**Clinical Pearl / High-Yield Fact**
Mircera's prolonged half-life allows for less frequent dosing, which can improve patient compliance and reduce the risk of dose-related adverse effects.
**Correct Answer:** C. Mircera